Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer

Colorectal cancer (CRC) is a major cause of mortality worldwide, associated with a steadily growing prevalence. Notably, the identification of KRAS, NRAS, and BRAF mutations has markedly improved targeted CRC therapy by affording treatments directed against the epidermal growth factor receptor (EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Valenzuela, Guillermo, Burotto, Mauricio, Marcelain, Katherine, González-Montero, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516650/
https://www.ncbi.nlm.nih.gov/pubmed/36187383
http://dx.doi.org/10.4251/wjgo.v14.i9.1654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516650/
https://www.ncbi.nlm.nih.gov/pubmed/36187383
http://dx.doi.org/10.4251/wjgo.v14.i9.1654

Ejemplares similares